Application 761240
- Type
- BLA
- Sponsor
- COHERUS BIOSCIENCES INC
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761240 | Loqtorzi | toripalimab-tpzi | 351(a) | Rx | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOQTORZI | TORIPALIMAB-TPZI | INJECTABLE;INJECTION | 240MG/6ML(40MG/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LOQTORZI | TORIPALIMAB-TPZI | Coherus Oncology, Inc. | 82e7921a-1e84-4988-9799-0ad7d19b2a75 | 2026-07-23 | Warnings, Adverse reactions | BLA761240 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.